GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Asset Impairment Charge

Longevity Biomedical (Longevity Biomedical) Asset Impairment Charge : $0.00 Mil (TTM As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Asset Impairment Charge?

Longevity Biomedical's Asset Impairment Charge for the six months ended in . 20 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Longevity Biomedical Asset Impairment Charge Historical Data

The historical data trend for Longevity Biomedical's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Asset Impairment Charge Chart

Longevity Biomedical Annual Data
Trend
Asset Impairment Charge

Longevity Biomedical Semi-Annual Data
Asset Impairment Charge

Longevity Biomedical Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Longevity Biomedical Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Asset Impairment Charge
Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Website
https://www.longevitybiomedical.com
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines